Home › Funds › UBS Group AG › DNA
UBS Group AG position in DNA
GINKGO BIOWORKS HOLDINGS INC · Health Care
Latest position (Q2 2026)691.66K sh
Reported value held$6.85M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 16.74K | $136.43K | New |
| Q4 2024 | 386.35K | $3.79M | Add |
| Q1 2025 | 282.62K | $1.61M | Reduce |
| Q2 2025 | 311.96K | $3.51M | Add |
| Q3 2025 | 262.56K | $3.83M | Reduce |
| Q4 2025 | 489.42K | $4.07M | Add |
| Q1 2026 | 582.80K | $3.57M | Add |
| Q2 2026 | 691.66K | $6.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNA
- BlackRock Inc 4.28M sh · $42.44M · Q2 2026
- Viking Global Investors 3.58M sh · $35.45M · Q2 2026
- Vanguard Group 2.90M sh · $24.11M · Q4 2025
- Baillie Gifford & Co 2.39M sh · $23.70M · Q2 2026
- Legal & General Investment Management America 1.67M sh · $16.54M · Q2 2026
- Geode Capital Management 1.22M sh · $12.11M · Q2 2026
- Millennium Management 638.68K sh · $6.33M · Q2 2026
- AQR Capital Management 621.62K sh · $6.16M · Q2 2026
- Goldman Sachs Group 607.38K sh · $6.02M · Q2 2026
- Bank of America Corp 545.85K sh · $5.41M · Q2 2026
- Renaissance Technologies 539.86K sh · $5.35M · Q2 2026